Sf-900™ II SFM
Sf-900™ II SFM
Gibco™

Sf-900™ II SFM

Sf-900™ II SFM es un medio de cultivo celular de insectos libre de suero y de proteínas optimizado para elMás información
Have Questions?
Cambiar vistabuttonViewtableView
Número de catálogoCantidad
10902096500 mL
109020881000 mL
109021046 x 1 L
Número de catálogo 10902096
Precio (MXN)
-
Cantidad:
500 mL
Customize this product
Sf-900™ II SFM es un medio de cultivo celular de insectos libre de suero y de proteínas optimizado para el crecimiento y el mantenimiento de células Spodoptera frugiperda (Sf9 y Sf21) y para la producción a gran escala de proteínas recombinantes expresadas mediante el sistema de vectores de expresión baculovirus (BEVS). Este medio es adecuado para los métodos de cultivo de suspensión y monocapa y apoya el crecimiento de otras líneas celulares de lepidópteros. Características de Sf-900™ II SFM:

• Crecimiento de alta densidad y a largo plazo superior
• Optimizado para la producción de proteínas recombinantes
• Formulación sin suero ni proteínas, y lista para su uso
• Escalable en biorreactores

Crecimiento de alta densidad y a largo plazo superior
Las células de Spodoptera frugiperda (Sf9) cultivadas en SFM Sf-900™ II alcanzan densidades celulares máximas de 9 a 12 x 106 células/ml, una mejora significativa con respecto a las formulaciones de la competencia y el medio Grace (consulte el manual del producto). También se observan aumentos del 20 al 100 % en las densidades celulares máximas con las líneas celulares Lymantria dispar (polilla gitana) y Trichoplusia ni (Tn-368; gusano falso medidor). El SFM Sf-900™ II es capaz de favorecer los cultivos a >20 pasajes.

Optimizado para la producción de proteínas recombinantes
Tradicionalmente, se ha utilizado medio de Grace complementado con un 10 % de FBS para la expresión de proteínas recombinantes. El SFM Sf-900™ II es un medio mejorado libre de suero y proteínas diseñado para el crecimiento de Sf9 y otras líneas de células de lepidópteros y la producción de virus de insectos y proteínas de ADNr.

Formulación libre de suero, sin proteínas y lista para su uso
El SFM Sf-900™ II es un medio libre de suero y sin proteínas que permite una purificación mucho más fácil de su proteína de interés. Sf-900™ II SFM está listo para usar; no requiere la adición de suero, glutamina o surfactantes. Las células adaptadas a otros medios libres de suero disponibles comercialmente se pueden subcultivar directamente en Sf-900™ II SFM, generalmente sin ninguna otra adaptación. Generalmente, las células requieren cierta adaptación de las formulaciones que contienen suero.

Escalable en biorreactores
La utilidad de SFM Sf-900™ II en sistemas de cultivo celular a gran escala se ha demostrado con un biorreactor Celligen™ de 5 l. Se llevaron a cabo con éxito infecciones con rAcNPV produciendo rβ-Gal y rEPO (consulte el manual del producto).

Uso del producto
Los clientes que utilicen el SFM Gibco™ Sf-900 II en un proceso de fabricación y deban presentar documentación a la Agencia estadounidense de alimentos y medicamentos (FDA) pueden solicitarnos una carta de autorización en la que se haga referencia a nuestro archivo principal sobre fármacos (DMF) de tipo II.

Sistema de fabricación y calidad conforme con las buenas prácticas de fabricación actuales
Para mantener la continuidad de la cadena de suministro, fabricamos el SFM Sf-900 II en dos instalaciones distintas, una ubicada en Grand Island (Nueva York, EE. UU.) y la otra en Escocia (Reino Unido). Ambos sitios cumplen los requisitos de producción según las buenas prácticas de fabricación actuales, cuentan con la certificación ISO 13485 y se han registrado en la FDA como fabricantes de dispositivos médicos.
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Línea de célulasSf21, Sf9
Tipo de célulaCélula de insecto
Línea de productosGibco, Sf-900
Tipo de productoMedio libre de suero (SFM) de células de insectos
Cantidad500 mL
Condiciones de envíoTemperatura ambiente
EspecieS. frugiperda, Spodoptera frugiperda
ClasificaciónSin proteínas, sin suero, sin suero
FormularioLíquido
Serum LevelSin suero
Con aditivosGlutamina
Unit SizeEach
Contenido y almacenamiento
Condiciones de almacenamiento: 2 °C a 8 °C. Proteger de la luz
Condiciones de envío: Ambiente
Vida útil: 12 meses a partir de la fecha de fabricación

Preguntas frecuentes

How do I adapt my cells to serum-free medium?

Cells can be adapted by Sequential or Direct Adaptation. Suggested protocols for each are below, and you can also find more information by searching "Adaptation of Cell Cultures to a Serum-Free Medium" from our website home page.

SEQUENTIAL ADAPTATION
1) Subculture the cells growing in serum-supplemented medium into a 25%:75% mixture of SFM and serum supplemented medium.
2) When the cell density is 5 x 10E5 cells/ml, subculture the cells into a 50%:50% mixture of SFM and serum supplemented medium at a cell density 2.5 x 10E5 to 3 x 10E5 cells/ml.
3) Continue to subculture after the cell density 5 x 10E5 cells/ml in gradually increasing proportions of SFM until the serum is ~0.1% with about 85% cell viability.
4) Subculture the cells into SFM with an innoculum of 2.5 x 10E5 to 3 x 10E5 cells/ml.
5) When the cell density is 1 x 10E6 to 3 x 10E6 cells/ml (4 to 6 days post planting) subculture the cells again.
6) Stock cultures of SFM adapted cells should be subcultured in SFM every 3 to 5 days when the cell density is 1 x 10E6 to 3 x 10E6 cells/ml with 90% viability.

DIRECT ADAPTATION
Some cells can be directly adapted from serum-containing medium to SFM. For direct adaptation, the cell innoculum should be 1.5 x 10E5 to 3 x 10E5 cells/ml.
Cells should be subcultured when the cell density is 1 x 10E6 to 3 x 10E6 cells/ml. Cells are fully adapted to SFM when the cell density is 2 x 10E6 to 4 x 10E6 cells/ml after 4 to 7 days in culture.
Stock cultures of cells adapted to SFM should be subcultured in SFM every 3 to 5 days when the cell density is 1 x 10E6 to 3 x 10E6 cells/ml with 90% viability.

Why is it necessary to gradually adapt the cells to serum-free medium?

Some cells, such as insect cells, are sensitive to changes in their medium. By sequentially adapting cells, the medium is changed with minimal effects on cell growth.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Can Sf9 cells in Sf-900 III SFM (Cat. No. 12659017) be thawed and grown in Sf-900 II SFM instead?

It should be okay to thaw the cells into Sf-900 II SFM. This is a richer media compared to the Sf-900 III SFM so the cells would have an easy time adapting. We would recommend taking the cells through 3 passages in the new medium before using them for any experiments as that they have enough time to adapt.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

What antimicrobials can be used in insect culture and at what concentration?

Many antibiotics are suitable for use with insect cells. The following antibiotics are commonly used:
- Penicillin/Streptomycine: 50-100 U/mL; 50-100 µg/mL
- Amphotericin B (Fungizone antimycotic): 0.25 µg/mL
- Gentamicin: 0.5 mL of 10 mg/mL solution in 500 mL media (final concentration: 10 µg/mL)

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Is it necessary to heat-inactivate my serum before adding it to my medium?

Heat inactivation is not necessary. Our team has routinely used serum that has not been heat-inactivated, and we have not observed any effect on cell growth or morphology.

Many cells do not require heat-inactivated FBS. Some cells prefer heat-inactivated FBS. For instance, we use heat-inactivated FBS for our insect cell lines, i.e., Sf9 and Sf21 cells.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Citations & References (16)

Citations & References
Abstract
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase.
Authors: Vickers Chad; Hales Paul; Kaushik Virendar; Dick Larry; Gavin James; Tang Jin; Godbout Kevin; Parsons Thomas; Baronas Elizabeth; Hsieh Frank; Acton Susan; Patane Michael; Nichols Andrew; Tummino Peter;
Journal:J Biol Chem
PubMed ID:11815627
'Human angiotensin-converting enzyme-related carboxypeptidase (ACE2) is a zinc metalloprotease whose closest homolog is angiotensin I-converting enzyme. To begin to elucidate the physiological role of ACE2, ACE2 was purified, and its catalytic activity was characterized. ACE2 proteolytic activity has a pH optimum of 6.5 and is enhanced by monovalent anions, which ... More
hsp90 is required for heme binding and activation of apo-neuronal nitric-oxide synthase: geldanamycin-mediated oxidant generation is unrelated to any action of hsp90.
Authors: Billecke Scott S; Bender Andrew T; Kanelakis Kimon C; Murphy Patrick J M; Lowe Ezra R; Kamada Yasuhiko; Pratt William B; Osawa Yoichi;
Journal:J Biol Chem
PubMed ID:11923316
'It is established that neuronal NO synthase (nNOS) is associated with the chaperone hsp90, although the functional role for this interaction has not been defined. We have discovered that inhibition of hsp90 by radicicol or geldanamycin nearly prevents the heme-mediated activation and assembly of heme-deficient apo-nNOS in insect cells. This ... More
The major conformational IgE-binding epitopes of hevein (Hev b6.02) are identified by a novel chimera-based allergen epitope mapping strategy.
Authors: Karisola Piia; Alenius Harri; Mikkola Jari; Kalkkinen Nisse; Helin Jari; Pentikäinen Olli T; Repo Susanna; Reunala Timo; Turjanmaa Kristiina; Johnson Mark S; Palosuo Timo; Kulomaa Markku S;
Journal:J Biol Chem
PubMed ID:11909866
'A novel approach to localize and reconstruct conformational IgE-binding epitope regions of hevein (Hev b6.02), a major natural rubber latex allergen, is described. An antimicrobial protein (AMP) from the amaranth Amaranthus caudatus was used as an immunologically non-IgE-binding adaptor molecule to which terminal or central parts of hevein were fused. ... More
Enhancing yield of infectious Bursal disease virus structural proteins in baculovirus expression systems: focus on media, protease inhibitors, and dissolved oxygen.
Authors: Hu Y C; Bentley W E;
Journal:Biotechnol Prog
PubMed ID:10585191
'Structural proteins of the poultry pathogen, infectious bursal disease virus (IBDV), were expressed in the baculovirus/insect cell expression system. To date, several reports have indicated that animal virus structural proteins are expressed only at low yield in this system. In this article, several factors were examined to enhance yield. These ... More
Crystal Structure of Imaginal Disc Growth Factor-2. A MEMBER OF A NEW FAMILY OF GROWTH-PROMOTING GLYCOPROTEINS FROM DROSOPHILA MELANOGASTER.
Authors: Varela Paloma F; Llera Andrea S; Mariuzza Roy A; Tormo Jose;
Journal:J Biol Chem
PubMed ID:11821393
'Imaginal disc growth factor-2 (IDGF-2) is a member of a recently described family of Drosophila melanogaster-soluble polypeptide growth factors that promote cell proliferation in imaginal discs. Although their precise mode of action has not been established, IDGFs cooperate with insulin in stimulating the growth of imaginal disc cells. We report ... More